Početna › Neuroblastom › Alabama
Kliničke studije za Neuroblastom u državi Alabama
8 studija za Neuroblastom traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
U tijeku regrutacijaFaza 3
Do 30 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- University of Alabama/Children's of Alabama, Birmingham
U tijeku regrutacijaFaza 2
Do 22 godina · Oba spola · Ažurirano 4. ruj 2026. · NCT02559778Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- University of Alabama/Children's of Alabama, Birmingham
U tijeku regrutacijaFaza 1/2
Do 26 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- University of Alabama/Children's of Alabama, Birmingham
U tijeku regrutacijaFaza 1/2
Do 30 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06541262Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospital of Alabama, Birmingham
U tijeku regrutacijaFaza 3
365 Days – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Alabama, Birmingham
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- University of Alabama/Children's of Alabama, Birmingham
U tijeku regrutacijaFaza 2
12 Months – 21 Years · Oba spola · Ažurirano 12. kol 2026. · NCT05489887A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital of Alabama/UAB, Birmingham
U tijeku regrutacijaFaza 2
18 Months – 40 Years · Oba spola · Ažurirano 12. kol 2025. · NCT05135975Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.